Specialized Investment Fund distribution now requires dedicated certification, while transitional recognition preserves existing qualified distributor...
Overlapping GST proceedings require Central and State authorities to designate one competent authority for coordinated adjudication of the same matter...
Composite healthcare supplies retain exemption when patient care is the contract's essential character, despite payment through an implementing agency...
Page of 4801
Press 'Enter' after typing page number.
921 to 940 of 96001 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
CESTAT held that the appeal by the appellant against the designated authority's final findings dated 29.09.2022 and the consequential notification dated 27.12.2022 imposing definitive anti-dumping duty on semi-finished ophthalmic lenses from China PR is maintainable. The court found section 134 of the Finance Act, 2023 (which purportedly amended ss. 9A and 9C of the Customs Tariff Act) has not come into force because no notification under s. 1(2)(b) of the Finance Act has been issued; accordingly, the pre-existing jurisdiction under s. 9C of the Customs Tariff Act remains effective. The appeal is admitted and listed for hearing on 23.09.2025.
CESTAT held that the appeal by the appellant against the designated authority's final findings dated 29.09.2022 and the consequential notification dated 27.12.2022 imposing definitive anti-dumping duty on semi-finished ophthalmic lenses from China PR is maintainable. The court found section 134 of the Finance Act, 2023 (which purportedly amended ss. 9A and 9C of the Customs Tariff Act) has not come into force because no notification under s. 1(2)(b) of the Finance Act has been issued; accordingly, the pre-existing jurisdiction under s. 9C of the Customs Tariff Act remains effective. The appeal is admitted and listed for hearing on 23.09.2025.
Note: It is a system-generated summary and is for quick reference only.